Delivery Order SPE2DR25D2106-SPE2DR26F1GLX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,052.78 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count) on January 22, 2026, with completion targeted for January 23, 2026. This non-competitive, firm fixed-price delivery order was fulfilled from the company's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under the parent organization Cencora, Inc., which operates the AmerisourceBergen brand and serves...
- The Defense Logistics Agency awarded a delivery order valued at $4,170.68 to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18-count package). This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 27, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,294.29 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,233.95 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg Vaginal Insert (8 count) on January 16, 2026, with completion scheduled for January 20, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,702.11 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (8-count packages) on December 22, 2025, with a completion date of December 23, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,641.52 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts on November 13, 2025, with completion expected by November 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.00 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,357.95 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal insert (18-pack) on December 17, 2025, with completion targeted for December 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1GLXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,368.50 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (18 count) on January 29, 2026, with completion expected by January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies, particularly the Department of Defense and military healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle supplying brand-name and generic medications, vaccines, and medical supplies to military treatment facilities and veterans' healthcare programs worldwide. The Yuvafem product, a hormone replacement therapy medication, represents one of the diverse pharmaceutical commodities the contractor delivers through its extensive federal medical supply portfolio, demonstrating the company's capability to fulfill varied healthcare procurement requirements for the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/28/26 |